Disruptive new medical technology that is patient-centered and solves the problem of comfort and compliance for prescribing healthcare providers while being reimburseable by insurers.

Plantar fasciitis and achilles tendinopathy treatment represents a large, underserved, and lacking area of patient care. Both indications affect 15% of the general population and increase up to 50% in athletic communities. Incidence is growing. Recovery is long. Recurrence is common. Current treatment solutions have high non-compliance rates. We are shifting that. And the results are life-changing.

Tested.